Open original FDA record ↗Recall record
- FDA identifier
- Z-0845-05
- Company in FDA record
- Baxter Healthcare Corp.
- FDA classification date
- May 17, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Possible occlusion of the Clearlink injection site valve due to inadequate silicone lubrication of the slit in the upper seal of the valve.
Source facts
- Action
- Recall letters dated 2/28/05 were sent to the direct accounts via first class mail on the same date to the attention of the Director of Nursing. The accounts were informed of the increase in reports of ClearLink valve occlusion, requested to examine their inventory for the affected lots of product, and call Baxter Healthcare Center for Service at 1-888-229-001 to return the affected product for credit. The letters included a copy of the Technical Letter revised 5/4/04, outlining the correct preparation and use ClearLink valve product, including detecting valve re-knits.
- Initiated
- 2005-02-28
- Root cause
- Other
- Terminated
- 2007-02-08
- Distribution
- Nationwide, including Puerto Rico and American Samoa, and internationally to Canada, Panama, Australia, New Zealand and Venezuela.
- Recall number
- Z-0845-05
- Recall status
- Terminated
- CDRH record ID
- 37492
- FDA classified
- 2005-05-17
- Recall event number
- 31245